Hematology/Oncology
RSSArticles
-
Beyond flu, SHEA calls for vaccine mandates
Targeting HCWs for all ACIP recommended shots -
'Passive payer' no more: New CMS requirements hitting hospital budgets
A broad array of new federal regulations on health care associated infections (HAIs) continue to come on line in 2014 and beyond, tying infection prevention more directly to the hospital bottom line than at any time in the field's history. -
How Should the Respiratory Muscles be Managed During Critical Illness?
Despite intense research on respiratory muscle physiology and patient-ventilator interfacing, this knowledge has not been integrated into a comprehensive approach toward managing the respiratory muscles in critical illness. This special feature describes the complex array of issues complicating such an endeavor. -
The 21/7 Combined OCP: Is It Time to Abandon This Formulation?
-
Continuous Use of Non-androgenic OC Improves Endometriosis Pain and Endometrioma Reoccurrence
Compared to cyclic use, a drospirenone-containing oral contraceptive pill used in a continuous fashion after the removal of an endometrioma is associated with a reduction in dysmenorrhea, non-menstrual pelvic pain, and reoccurrence of endometrioma formation. -
Annual Mammography Screening: The Debate Continues
Although annual screening mammography did increase the detection rate of non-palpable tumors, it did not reduce mortality from breast cancer over 25 years of follow-up. -
Adding to Survival ( Again): Cervix Cancer
Bevacizumab added to chemotherapy, particularly paclitaxel and cisplatin, was efficacious in all response outcomes (objective response, progression-free survival, and overall survival) without diminution in quality of life or unacceptable toxicity. -
Improving Adherence: Who's Doing the Work?
Approximately 50% of patients with chronic illnesses do not adhere to indicated medications, treatment regimens, and healthy lifestyle changes.
-
Efficacy of Higher-dose Oseltamivir in Adults with Influenza A and B
In a prospective, open-label, intervention study conducted over four influenza seasons, higher dose oseltamivir compared to standard dose produced no additional benefits in patients with influenza A infection. It did lead to improved virologic response in those with influenza B, but this did not reach statistical significance. -
Does the AV Block Get Worse?